 | • レポートコード：MRC2203A265 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本市場調査レポートでは、世界のコンパニオンアニマル医療市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品種類別（治療、診断）分析、動物種類別（犬、猫、その他コンパニオンアニマル）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来傾向など、以下の構成でまとめました。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界のコンパニオンアニマル医療市場規模：製品種類別（治療、診断） ・世界のコンパニオンアニマル医療市場規模：動物種類別（犬、猫、その他コンパニオンアニマル） ・世界のコンパニオンアニマル医療市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Bayer AG、Elanco Animal Health、Merck & Co.、…） ・市場機会・将来傾向 |
Certain factors that are responsible for the growth of the companion animal healthcare market are increasing pet adoption across the world, rising government initiatives for animal health, and growing technological advancements in animal healthcare.
The popular nuclear family trend across the world has accelerated pet ownership and is expected to continue during the forecast period.
Over the years, the trend of imbuing pets with human characteristics has increased the health and safety concerns among pet owners. This increase is a result of the growing human-animal bond, which defines consumers’ willingness to spend more money on their pets. Further, the rising demand for pet healthcare insurance in the United States is expected to support this argument.
Key Market Trends
Vaccines are Expected to Dominate the Therapeutics Segment
Diseases related to companion animals are more probable to get transmitted to the human population. The bite caused by dogs and cats develops many infections in humans. Other diseases such as neoplasia, distemper, parvovirus, leukaemia, panleukopenia, and viral rhinotracheitis are found in various pet animals. many of these diseases are fatal even with proper medication, so the majority of the pet owners get the animals vaccinated regularly. Vaccination becomes essential for pets as well as humans to protect against such diseases. The increasing demand for prophylactic vaccines will increase segment growth.
Asia-Pacific Region is the Fastest Growing Region in the Forecast Period
The APAC region is an important and high potential market. The Western matured markets are in contrast to the Asian countries, which are expected to have higher growth potential during the forecast period. Further, over the past several years, the market has witnessed a steady growth, owing to the changing perception of pet treatment and the growing nuclear family system, in the region.
The region is endowed with a diverse set of markets. The Australian and Japanese markets are more aware of pet products and have quality-conscious pet owners. The buying pattern and social culture of pet owners make them stand out from most of the other countries in the region. The Indian, Chinese, and Indonesian markets are rapidly emerging markets, with great potential for growth during the forecast period. Economies, such as Taiwan, Malaysia, and South Korea, are a few ideal targets for pet care companies.
Competitive Landscape
The market for companion animal healthcare is majorly dominated by a few players, such as Zoetis Inc., Bayer AG, Elanco, Virbac, etc. The largest share of the market is captured by these global players. However, there are few companies that are penetrating the market currently and are expected to hold a substantial share in the market.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in Pet Adoption, mostly by Nuclear Families
4.2.2 Rise in the Number of Initiatives by Governments and Animal Welfare Associations
4.2.3 Advanced Technology in Animal Healthcare
4.3 Market Restraints
4.3.1 Use of Counterfeit Medicines
4.3.2 Increasing Costs of Animal Testing and Veterinary Care
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 By Therapeutics
5.1.1.1 Vaccines
5.1.1.2 Parasiticides
5.1.1.3 Anti-Infectives
5.1.1.4 Medical Feed Additives
5.1.1.5 Other Therapeutics
5.1.2 By Diagnostics
5.1.2.1 Immunodiagnostic Tests
5.1.2.2 Molecular Diagnostics
5.1.2.3 Diagnostic Imaging
5.1.2.4 Other Diagnostics
5.2 By Animal Type
5.2.1 Dogs
5.2.2 Cats
5.2.3 Other Companion Animals
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bayer AG
6.1.2 Elanco Animal Health
6.1.3 Merck & Co.
6.1.4 Merial
6.1.5 Virbac
6.1.6 Vetoquinol SA
6.1.7 Zoetis Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS